Property modulation with chemical transformations
US-12497712-B2 · Dec 16, 2025 · US
Benzenesulfonamido-pyrimidines
Benzenesulfonamido-pyrimidines · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D239/69 |
| Official title | Benzenesulfonamido-pyrimidines |
| Display label | Benzenesulfonamido-pyrimidines |
| Total patents | 61 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Cystic fibrosis transmembrane conductance regulator modulating agents
US-12421251-B2 · Sep 23, 2025 · US
IRE1 small molecule inhibitors
US-12404248-B2 · Sep 2, 2025 · US
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
US-12246008-B2 · Mar 11, 2025 · US
Ire1 small molecule inhibitors
US-2024287004-A1 · Aug 29, 2024 · US
IRE1 small molecule inhibitors
US-11945784-B2 · Apr 2, 2024 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2023373939-A1 · Nov 23, 2023 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2023373935-A1 · Nov 23, 2023 · US
A method of forming a conjugate of a sulfonamide and a polypeptide
US-2023346949-A1 · Nov 2, 2023 · US
Mixtures and compositions comprising 5-fluoro-4-imino-3- methyl-1-tosyl-3,4-dihydropyrimidin-2-one, and methods of use thereof
US-2023292746-A1 · Sep 21, 2023 · US
Methods for treating anemia using an actriib ligand trap and fedratinib
US-2023181690-A1 · Jun 15, 2023 · US
6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity
US-2023137585-A1 · May 4, 2023 · US
BCL-2 inhibitors and their use as pharmaceuticals
US-11622970-B2 · Apr 11, 2023 · US
Cystic fibrosis transmembrane conductance regulator modulating agents
US-2022372047-A1 · Nov 24, 2022 · US
Forms of fedratinib dihydrochloride
US-11306062-B2 · Apr 19, 2022 · US
Benzenesulfonamide compounds and their use as therapeutic agents
US-11299490-B2 · Apr 12, 2022 · US
Therapeutic compounds and methods of use thereof
US-2022081423-A1 · Mar 17, 2022 · US
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
US-11274077-B2 · Mar 15, 2022 · US
Ire1 small molecule inhibitors
US-2022024878-A1 · Jan 27, 2022 · US
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
US-2022000844-A1 · Jan 6, 2022 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D239/69?
- CPC C07D239/69 is the Cooperative Patent Classification code for “Benzenesulfonamido-pyrimidines.”
- How many patents are filed under CPC C07D239/69 (Benzenesulfonamido-pyrimidines)?
- Our database includes 61 publications tagged with this CPC code.
- Is patent activity under CPC C07D239/69 growing?
- Publication counts under this code: 2 in 2024 vs 4 in 2025 (latest complete years).